LINEAGE THERAP earnings per share and revenue

LCTX earnings per share for the last quarter are -0.11 ILS whereas the estimation was -0.17 ILS which accounts for 33.33% surprise. Company revenue for the same period amounts to 5.32 M ILS despite the estimated figure of 3.56 M ILS. Estimated earnings per share for the next quarter are -0.15 ILS, and revenue is expected to reach 3.86 M ILS. Also watch annual changes over time to get a bigger picture of LCTX earnings per share and revenue dynamics.